The Winnipeg Free Press reported today that local company, Cangene, is in the process of acquiring the bankrupt US company Ipsen and Inspiration Biopharmaceuticals, Inc. Ipsen and Inspiration Biopharmaceticals have a hemophilia B product in phase III trials. To see articles:

http://www.winnipegfreepress.com/business/Cangene-to-acquire-hemophilia-compound-in-mutltimillion-dollar-deal-190048031.html

www.bizjournals.com/boston/blog/bioflash/2013/02/inspiration-sells-off-remaining.html